Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Little Green Pharma Ltd. ( (AU:LGP) ) just unveiled an announcement.
Little Green Pharma has invited shareholders to an investor webinar on 3 February 2026, where Managing Director Paul Long will outline the company’s proposed merger with Cannatrek Ltd and provide an update on its quarterly results. The Zoom-based session, which will include a moderated Q&A and be recorded for later viewing on the company’s website, signals an effort to engage investors more closely around a transaction that could reshape LGP’s scale and market reach in the competitive global medicinal cannabis sector.
The most recent analyst rating on (AU:LGP) stock is a Buy with a A$0.18 price target. To see the full list of analyst forecasts on Little Green Pharma Ltd. stock, see the AU:LGP Stock Forecast page.
More about Little Green Pharma Ltd.
Little Green Pharma Ltd (ASX:LGP) is a global medicinal cannabis company with vertically integrated operations across Europe and Australia. It produces and distributes a diverse portfolio of cannabis-based medicines through wholesalers, pharmacies, clinics and GPs in Australia and more than 12 export markets, and also earns revenue via its Health House distribution business. With three production facilities in Denmark and Australia, including one of Europe’s largest, LGP ranks among the top suppliers in Australia and is a leading provider into France, Germany and the UK, giving investors leveraged exposure to growing international medicinal cannabis demand.
Average Trading Volume: 232,815
Technical Sentiment Signal: Hold
Current Market Cap: A$38.21M
See more data about LGP stock on TipRanks’ Stock Analysis page.